| Record ID | marc_records_scriblio_net/part15.dat:177189714:1328 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part15.dat:177189714:1328?format=raw |
LEADER: 01328cam 22003737a 4500
001 2005391715
003 DLC
005 20050802163539.0
008 040709s2004 enka b 000 0 eng
010 $a 2005391715
016 7 $a101223808$2DNLM
020 $a1898563969
035 $a(OCoLC)ocm55879419
040 $aNLM$cNLM$dOUN$dOCLCQ$dDLC
042 $anlmcopyc$alccopycat
050 00 $aQR201.S68$bS855 2004
082 00 $a579.3/53$222
060 00 $a2004 H-643
060 10 $aQW 142.5.C6$bS7939 2004
245 00 $aStaphylococcus aureus :$bmolecular and clinical aspects /$ceditors, Dlawer A.A. Ala'Aldeen, Keiichi Hiramatsu.
260 $aChichester, U.K. :$bHorwood Pub.,$cc2004.
300 $axiv, 267 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references.
650 0 $aStaphylococcus aureus.
650 0 $aStaphylococcus aureus infections.
650 0 $aStaphylococcus aureus infections$xEpidemiology.
650 0 $aStaphylococcus aureus infections$xPathogenesis.
650 0 $aStaphylococcus aureus$xGenetic aspects.
650 12 $aStaphylococcal Infections$xepidemiology.
650 12 $aStaphylococcus aureus$xgenetics.
650 22 $aDrug Resistance, Bacterial.
650 22 $aStaphylococcus aureus$xpathogenicity.
700 1 $aAla'Aldeen, Dlawer A. A.
700 1 $aHiramatsu, Keiichi,$d1949-